(Q40821917)
Statements
1 reference
Intermediate and high-dose ARA-C and m-AMSA (or daunorubicin) as remission and consolidation treatment for patients with relapsed acute leukaemia and lymphoblastic non-Hodgkin lymphoma (English)
1 reference
Willemze R
1 reference
Peters WG
1 reference
van Hennik MB
1 reference
Fibbe WE
1 reference
Kootte AM
1 reference
van Berkel M
1 reference
Lie R
1 reference
Rodenburg CJ
1 reference
Veltkamp JJ
1 reference
1 January 1985
1 reference
1 reference
34
1 reference
1
1 reference
83-87
1 reference
Identifiers
1 reference